---
title: "002675.SZ (002675.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002675.SZ/news.md"
symbol: "002675.SZ"
name: "002675.SZ"
parent: "https://longbridge.com/en/quote/002675.SZ.md"
datetime: "2026-03-04T15:31:25.033Z"
locales:
  - [en](https://longbridge.com/en/quote/002675.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002675.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002675.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/002675.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002675.SZ/news.md)


# 002675.SZ (002675.SZ) — Related News

### [Dongcheng Biochem: Has repurchased 4.0287 million shares, using a total of 57.1719 million yuan](https://longbridge.com/en/news/274411585.md)
*2026-02-01T07:48:22.000Z*
> On February 1st, Dongcheng Biochem announced that as of January 31, 2026, the company repurchased 4,028,699 shares of it

### [Pre-market announcement gold mining: FII's AI server business surges! Revenue in Q4 2025 is expected to grow over 50% quarter-on-quarter and over 5.5 times year-on-year; HXCX's net profit in 2025 is expected to increase by over 16 times year-on-year](https://longbridge.com/en/news/274064167.md)
*2026-01-29T00:31:14.000Z*
> FII expects a year-on-year net profit growth of 56%-63% in the fourth quarter of 2025, with AI server business revenue i

### [Dongcheng Biochem: Heparin sodium raw materials pass US FDA inspection](https://longbridge.com/en/news/273963227.md)
*2026-01-28T09:04:57.000Z*
> Dongcheng Biochem announced that from December 8 to December 11, 2025, the company underwent a cGMP on-site inspection b

### [The National Medical Products Administration held a work promotion meeting for the boron neutron capture therapy system](https://longbridge.com/en/news/273154620.md)
*2026-01-21T01:21:03.000Z*
> The National Medical Products Administration held a working meeting in Beijing on the boron neutron capture therapy syst

### [Dongcheng Biochem: The application for the listing of Fluorine [18F] Siretu Injection has been accepted](https://longbridge.com/en/news/272072744.md)
*2026-01-09T12:10:03.000Z*
> Dongcheng Biochem's subsidiary Yantai Lanna Bio-Tech Co., Ltd. has received the "Acceptance Notice" from the National Me

### [Dongcheng Biochem: Received a commitment for a special loan for stock repurchase from financial institutions not exceeding 170 million yuan](https://longbridge.com/en/news/271911221.md)
*2026-01-08T09:49:32.000Z*
> Dongcheng Biochem announced that on December 31, 2025, the company plans to repurchase shares through a centralized bidd

### [Repurchase, increase holdings, and dividends: multiple measures taken by Shenzhen Stock Exchange companies to safeguard market stability with "real money."](https://longbridge.com/en/news/271432862.md)
*2026-01-04T20:47:28.000Z*
> Companies listed on the Shenzhen Stock Exchange continue to repurchase and increase holdings, conveying market confidenc

### [Dongcheng Biochem plans to repurchase company shares worth 100 million to 200 million yuan](https://longbridge.com/en/news/271416585.md)
*2026-01-04T09:18:03.000Z*
> Dongcheng Biochem announced plans to repurchase a portion of its publicly held shares through centralized bidding, with 

### [Dongcheng Biochem: The "Radioactive Drug Medical Isotope Technology Joint Research Center" is inaugurated](https://longbridge.com/en/news/270937407.md)
*2025-12-29T01:33:48.000Z*
> According to Dongcheng Biochem, on December 28th, a comprehensive cooperation and exchange signing ceremony was held bet